KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.47 $1.47 Thursday, 10th Nov 2022 EPZM stock ended at $1.47. During the day the stock fluctuated 0% from a day low at $1.47 to a day high of $1.47.
90 days $1.47 $1.47
52 weeks $0.411 $4.88

Historical Epizyme prices

Date Open High Low Close Volume
Mar 10, 2020 $20.88 $20.90 $19.55 $20.53 1 313 583
Mar 09, 2020 $19.93 $20.88 $19.51 $20.00 956 239
Mar 06, 2020 $21.90 $22.68 $21.20 $21.67 696 766
Mar 05, 2020 $21.75 $23.61 $21.68 $22.71 784 692
Mar 04, 2020 $21.59 $22.55 $21.52 $22.30 1 007 691
Mar 03, 2020 $23.01 $23.01 $20.59 $20.72 1 023 884
Mar 02, 2020 $21.69 $23.23 $20.86 $22.99 1 182 064
Feb 28, 2020 $19.44 $21.42 $19.01 $21.38 780 683
Feb 27, 2020 $21.00 $21.38 $20.02 $20.47 825 358
Feb 26, 2020 $21.67 $22.81 $20.88 $21.64 1 032 176
Feb 25, 2020 $22.18 $22.95 $21.00 $21.49 1 002 454
Feb 24, 2020 $21.00 $22.31 $20.55 $21.64 1 581 510
Feb 21, 2020 $25.49 $25.49 $24.67 $24.88 720 729
Feb 20, 2020 $25.14 $25.60 $24.26 $25.48 577 210
Feb 19, 2020 $25.29 $25.98 $25.05 $25.18 861 856
Feb 18, 2020 $24.19 $25.41 $24.02 $25.25 751 423
Feb 14, 2020 $22.83 $24.39 $22.65 $24.26 950 503
Feb 13, 2020 $22.53 $22.96 $22.16 $22.23 319 147
Feb 12, 2020 $22.38 $22.83 $21.81 $22.73 343 480
Feb 11, 2020 $22.47 $22.47 $21.74 $22.22 428 391
Feb 10, 2020 $21.38 $22.75 $21.32 $22.28 821 423
Feb 07, 2020 $21.62 $21.73 $20.96 $21.35 346 442
Feb 06, 2020 $21.91 $22.30 $21.67 $21.78 378 660
Feb 05, 2020 $21.86 $22.29 $21.67 $21.89 491 231
Feb 04, 2020 $21.92 $22.00 $20.70 $21.62 1 242 896
Click to get the best stock tips daily for free!

About Epizyme

Epizyme Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in pa... EPZM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT